Indeed, studies show that a 10-day treatment of U87 primary glioblastoma multiforme, (GBM) xenografts with Torin 1 resulted in a robust activation of the PI3K/Akt/mTOR pathway and tumor growth suppression by over 99% [54]. This evidence concerns the gene MTOR and glioblastoma.